Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities
Certara(CERT) Newsfilter·2025-04-01 12:00"We're advancing the Simcyp Simulator to address the evolving needs of our pharmaceutical collaborators and regulators," Rob Aspbury, President, Certara Predictive Technologies said. "Simcyp Version 24 supports the growing adoption of PBPK in drug development and regulatory decision-making, as well as the broader applications of PBPK from discovery through clinical development." RADNOR, Pa., April 01, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (NASDAQ:CERT), a global leader in model-informed drug development, h ...